vs

Side-by-side financial comparison of COMMUNITY TRUST BANCORP INC (CTBI) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $74.7M, roughly 1.1× COMMUNITY TRUST BANCORP INC). COMMUNITY TRUST BANCORP INC runs the higher net margin — 36.5% vs -38.1%, a 74.6% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 13.8%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 12.8%).

Community Trust Bancorp is an American regional bank holding company that was founded in 1903 as Pikeville National Bank. The renamed corporation continues to have its headquarters in Pikeville, Kentucky, at the heart of Appalachia. Community Trust Bancorp operates a commercial bank, Community Trust Bank, and a trust company, Community Trust and Investment Company of Lexington.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

CTBI vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.1× larger
PRCT
$83.1M
$74.7M
CTBI
Growing faster (revenue YoY)
PRCT
PRCT
+6.4% gap
PRCT
20.2%
13.8%
CTBI
Higher net margin
CTBI
CTBI
74.6% more per $
CTBI
36.5%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
12.8%
CTBI

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CTBI
CTBI
PRCT
PRCT
Revenue
$74.7M
$83.1M
Net Profit
$27.3M
$-31.6M
Gross Margin
64.9%
Operating Margin
47.3%
-4.1%
Net Margin
36.5%
-38.1%
Revenue YoY
13.8%
20.2%
Net Profit YoY
21.3%
-27.9%
EPS (diluted)
$1.51
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTBI
CTBI
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$74.7M
$76.4M
Q3 25
$71.5M
$83.3M
Q2 25
$70.2M
$79.2M
Q1 25
$66.2M
$69.2M
Q4 24
$65.7M
$68.2M
Q3 24
$62.8M
$58.4M
Q2 24
$61.4M
$53.4M
Net Profit
CTBI
CTBI
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$27.3M
$-29.8M
Q3 25
$23.9M
$-21.4M
Q2 25
$24.9M
$-19.6M
Q1 25
$22.0M
$-24.7M
Q4 24
$22.5M
$-18.9M
Q3 24
$22.1M
$-21.0M
Q2 24
$19.5M
$-25.6M
Gross Margin
CTBI
CTBI
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
CTBI
CTBI
PRCT
PRCT
Q1 26
-4.1%
Q4 25
47.3%
-40.6%
Q3 25
43.2%
-27.8%
Q2 25
46.2%
-28.0%
Q1 25
42.9%
-39.7%
Q4 24
44.7%
-28.9%
Q3 24
43.8%
-38.4%
Q2 24
42.3%
-50.3%
Net Margin
CTBI
CTBI
PRCT
PRCT
Q1 26
-38.1%
Q4 25
36.5%
-39.1%
Q3 25
33.4%
-25.7%
Q2 25
35.5%
-24.7%
Q1 25
33.2%
-35.8%
Q4 24
34.2%
-27.6%
Q3 24
35.3%
-35.9%
Q2 24
31.8%
-48.0%
EPS (diluted)
CTBI
CTBI
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$1.51
$-0.54
Q3 25
$1.32
$-0.38
Q2 25
$1.38
$-0.35
Q1 25
$1.22
$-0.45
Q4 24
$1.25
$-0.34
Q3 24
$1.23
$-0.40
Q2 24
$1.09
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTBI
CTBI
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$363.7M
$245.6M
Total DebtLower is stronger
$63.8M
$51.7M
Stockholders' EquityBook value
$856.1M
$347.7M
Total Assets
$6.7B
$487.1M
Debt / EquityLower = less leverage
0.07×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTBI
CTBI
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$363.7M
$286.5M
Q3 25
$507.6M
$294.3M
Q2 25
$395.3M
$302.7M
Q1 25
$340.7M
$316.2M
Q4 24
$369.5M
$333.7M
Q3 24
$240.9M
$196.8M
Q2 24
$161.7M
$214.1M
Total Debt
CTBI
CTBI
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$63.8M
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$64.0M
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
CTBI
CTBI
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$856.1M
$365.9M
Q3 25
$831.4M
$380.3M
Q2 25
$806.9M
$385.8M
Q1 25
$784.2M
$389.2M
Q4 24
$757.6M
$402.2M
Q3 24
$760.8M
$241.2M
Q2 24
$719.3M
$251.8M
Total Assets
CTBI
CTBI
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$6.7B
$508.1M
Q3 25
$6.6B
$511.5M
Q2 25
$6.4B
$513.1M
Q1 25
$6.3B
$519.4M
Q4 24
$6.2B
$534.0M
Q3 24
$6.0B
$374.1M
Q2 24
$5.8B
$374.4M
Debt / Equity
CTBI
CTBI
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.07×
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.08×
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTBI
CTBI
PRCT
PRCT
Operating Cash FlowLast quarter
$105.0M
Free Cash FlowOCF − Capex
$97.4M
FCF MarginFCF / Revenue
130.3%
Capex IntensityCapex / Revenue
10.2%
Cash ConversionOCF / Net Profit
3.85×
TTM Free Cash FlowTrailing 4 quarters
$181.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTBI
CTBI
PRCT
PRCT
Q1 26
Q4 25
$105.0M
$-10.3M
Q3 25
$37.5M
$-6.6M
Q2 25
$15.9M
$-15.0M
Q1 25
$36.6M
$-17.0M
Q4 24
$105.3M
$-32.4M
Q3 24
$36.7M
$-18.8M
Q2 24
$20.0M
$-15.7M
Free Cash Flow
CTBI
CTBI
PRCT
PRCT
Q1 26
Q4 25
$97.4M
$-12.2M
Q3 25
$36.4M
$-9.5M
Q2 25
$13.6M
$-17.8M
Q1 25
$34.5M
$-18.8M
Q4 24
$97.2M
$-33.6M
Q3 24
$35.4M
$-19.0M
Q2 24
$18.4M
$-16.8M
FCF Margin
CTBI
CTBI
PRCT
PRCT
Q1 26
Q4 25
130.3%
-15.9%
Q3 25
50.8%
-11.4%
Q2 25
19.3%
-22.5%
Q1 25
52.2%
-27.2%
Q4 24
148.0%
-49.2%
Q3 24
56.4%
-32.6%
Q2 24
30.1%
-31.4%
Capex Intensity
CTBI
CTBI
PRCT
PRCT
Q1 26
Q4 25
10.2%
2.4%
Q3 25
1.7%
3.4%
Q2 25
3.4%
3.5%
Q1 25
3.1%
2.7%
Q4 24
12.3%
1.7%
Q3 24
2.1%
0.4%
Q2 24
2.5%
2.0%
Cash Conversion
CTBI
CTBI
PRCT
PRCT
Q1 26
Q4 25
3.85×
Q3 25
1.57×
Q2 25
0.64×
Q1 25
1.66×
Q4 24
4.68×
Q3 24
1.66×
Q2 24
1.02×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTBI
CTBI

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons